Abstract
Kigamicin D did not show any immunosuppressive activity in mixed lymphocyte culture reaction and mitogen induced lymphocyte blastogenesis in vitro and graft versus host reaction in vivo. Natural killer cell activity in spleen cells was not affected by oral administration of kigamicin D. Instead, delayed-type hypersensitivity response to sheep red blood cells was stimulated at a broad dosage level. It is concluded that kigamicin D increases cellular immunity to specific antigen.
Similar content being viewed by others
Article PDF
References
Kunimoto S, Lu J, Esumi H, Yamazaki Y, Kinoshita N, Honma Y, Hamada M, Ohsono M, Ishizuka M, Takeuchi T . Kigamicins, novel antitumor antibiotics. I. Taxonomy, isolation, physico-chemical properties and biological activities. J Antibiot 56: 1004–1011 ( 2003)
Lu J, Kunimoto S, Yamazaki Y, Kaminishi M, Esumi H . Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation. Cancer Sci 95: 547–552 ( 2004)
Ishizuka M, Masuda T, Kanbayashi N, Fukasawa S, Takeuchi T, Aoyagi T, Umezawa H . Effect of bestatin on mouse immune system and experimental murine tumors. J Antibiot 33: 642–652 ( 1980)
Masuda T, Ohba S, Kawada M, Osono M, Ikeda D, Esumi H, Kunimoto S . Antitumor effect of kigamicin D on mouse tumor models. J Antibiot 59: 209–214 ( 2006)
Ishizuka M, Masuda T, Mizutani S, Osono M, Kumagai H, Takeuchi T, Umezawa H . Induction of antitumor resistance to mouse leukemia L1210 by spergualins. J Antibiot 32: 1736–1743 ( 1986)
Ishizuka M, Sato J, Sugiyama Y, Takeuchi T, Umezawa H . Mitogenic effect of bestatin on lymphocytes. J Antibiot 33: 653–662 ( 1980)
Ford WL . Measurement of graft versus-host activity. In: Weilerz DM (ed.). Handbook of Experimental Immunology. Blackwell Scientific Publication, Oxford, pp. 30.1–30.12 ( 1978)
Ayalon O, Hughes EA, Creswell P, Lee J, O'Donnell L, Pardi R, Bender JR . Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc Natl Acad Sci USA 95: 2435–2440 ( 1998)
Masuda T, Mizutani S, Iijima M, Odai H, Suda H, Ishizuka M, Takeuchi T, Umezawa H . Immunosuppressive activity of 15-deoxyspergualin and its effect on skin allografts in rats. J Antibiot 40: 1612–1618 ( 1987)
Kawada M, Kawatsu M, Masuda T, Ohba S, Amemiya M, Kohama T, Ishizuka M, Takeuchi T . Specific inhibitors of protein phosphatase 2A inhibit tumor metastasis through augmentation of natural killer cells. Int Immunopharmacol 3: 179–188 ( 2003)
Fukao T, Koyasu S . PI3K and negative regulation of TLR signaling. Trends Immunol 24: 358–363 ( 2003)
Masuda T, Ikeda D, Esumi H, Kunimoto S . Selective cytotoxicity of kigamicin D to PANC-1 cells under nutrient deprived medium in vitro. J Antibiot 59: xxx–xxx ( 2006)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Masuda, T., Ohba, S., Kawada, M. et al. Augmentation of Cellular Immunity by Kigamicin D. J Antibiot 59, 215–219 (2006). https://doi.org/10.1038/ja.2006.30
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2006.30
Keywords
This article is cited by
-
Antitumor Effect of Kigamicin D on Mouse Tumor Models
The Journal of Antibiotics (2006)